Back to Search
Start Over
PD1 and PDL1 upregulation and survival after decitabine treatment in lower risk MDS
- Source :
- Leukemialymphoma. 58(4)
- Publication Year :
- 2016
-
Abstract
- The myelodysplastic syndromes (MDS) represent a diverse group of myeloid clonal disorders, characterized by one or more cytopenias and potential progression to acute myeloid leukemia (AML). The pre...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Myeloid
Decitabine
Lower risk
B7-H1 Antigen
03 medical and health sciences
0302 clinical medicine
Text mining
Downregulation and upregulation
hemic and lymphatic diseases
Internal medicine
Medicine
Humans
business.industry
Myelodysplastic syndromes
Myeloid leukemia
Hematology
medicine.disease
Up-Regulation
medicine.anatomical_structure
030220 oncology & carcinogenesis
Myelodysplastic Syndromes
Azacitidine
business
human activities
030215 immunology
medicine.drug
Subjects
Details
- ISSN :
- 10292403
- Volume :
- 58
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Leukemialymphoma
- Accession number :
- edsair.doi.dedup.....01c473761c863f51be04794284337fb6